A portion of the proceeds from the SITC National Conference will be donated to the following charities:
LUNGevity connects people to lung cancer survivorship through research, education and support. Why do we focus on research? Because the link between research spending and improved survival is clear. Survival rates have dramatically improved for colorectal, breast, and prostate cancers over the last several decades along with the exponential growth in their research spending. We want to do the same for lung cancer, whose five-year survival rate is only 16%. To date, LUNGevity-funded projects represent almost $16 million spent on 100 research projects at 56 institutions in 23 states. LUNGevity research investments focus on early detection, because the survival rate jumps when lung cancer is detected while still localized. We also focus on personalizing treatment approaches through biomarkers—getting the right treatment to the right patient at the right time.
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today. Watch our video to find out how we will get to a cure.